Newsroom

CARNEGIE, Pa.--(BUSINESS WIRE)--Ampco-Pittsburgh Corporation (NYSE: AP) will hold a conference call on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time (ET) to discuss its financial results for the second quarter ended June 30, 2026. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 8:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the follo...

BOCA RATON, Fla.--(BUSINESS WIRE)--SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended June 30, 2026. Highlights of the second quarter include: Net income attributable to SBA of $198.8 million or $1.87 per share Industry-leading AFFO per share of $3.05 Issued inaugural $3.5 billion investment grade senior notes and entered into a new expanded $2.5 billion senior unsecured revolving credit facility subsequent to quarter end Ratings...

FREMONT, Calif.--(BUSINESS WIRE)--Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced second quarter 2026 financial results. Second quarter 2026 highlights: Revenue of $294.8 million, up 15% compared to Q1 2026 and up 24% compared to Q2 2025; Gross margin of 13.9% on a GAAP basis and 14.1% on a non‑GAAP basis; Earnings per share of $0.03 on a GAAP bas...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today reported financial results for the second quarter ended June 30, 2026, and provided business updates including progress of the global Pha...

DENVER--(BUSINESS WIRE)--Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the second quarter ended June 30, 2026. “In the second quarter, we delivered record results, with both revenue and earnings per share exceeding the high end of our guidance,” said Steve Kelley, president and CEO of Advanced Energy. “Demand continues to strengthen across all of our markets,...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the second quarter ended June 30, 2026, and updated its full year 2026 revenue guidance. “Vertex delivered excellent second quarter results, expanding our leadership in cystic fibrosis; delivering strong revenue growth in sickle cell disease, beta thalassemia, and acute pain; and with the pending acquisition of Crinetics, adding rare endocrine diseases as our fifth pilla...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to six newly hired non-executive employees consisting of options to purchase an aggregate of 115,600 common shares of the Company (the "Options") with effective grant dates of August 3, 2026...

NEW YORK--(BUSINESS WIRE)--AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi”), a leading independent global wealth manager with approximately $90 billion in assets, today announced it will release its financial results for the second quarter 2026 after the market close on Monday, August 10, 2026. Management will host a conference call and webcast the same day at 5:00pm Eastern Time to provide a business update and discuss the financial results for the quarter. Conference Call Information Participants ar...

SAN DIEGO--(BUSINESS WIRE)--BioSurplus, one of the most recognized names in the life science equipment industry, has officially returned. For decades, BioSurplus helped organizations maximize the value of surplus laboratory assets while providing scientists and businesses with access to quality pre-owned equipment through one of the industry's most recognized online marketplaces. The return of the BioSurplus brand brings back a familiar resource for equipment buyers and sellers alike. Headquart...

PARIS--(BUSINESS WIRE)--Regulatory News: Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des Marchés Financiers, Claranova SE (Paris:ALCLA) (ISIN FR0013426004) publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 31 juillet 2026 :   Actions composant le capital 57 206 910 Droits de vote théoriques (A) 57 206 910   Actions privées de droits de vote Autodétention au nominatif (B) 22 973 Auto...